Neurotransmitter transporters are key components of synapses. They are mainly located in the cell membranes of nerve endings, where they terminate the action of released neurotransmitters through reuptake.
Because of their important roles in depression and neurodegenerative diseases, including Alzheimer’s disease and Parkinson’s disease, neurotransmitter transporters have become an important class of drug targets.
ICE Bioscience provides cell-based neurotransmitter transporter detection models to evaluate the effects of candidate drugs on transporter activity.

Figure 1. Concentration–response curve of a ligand in HEK cells expressing neurotransmitter transporter genes.
ICE Bioscience provides fast and efficient compound analysis services to determine excitatory and inhibitory activities, as well as lead-compound selectivity across various drug targets. These results support faster compound selection during hit-to-lead development.
We value your inquiries and are here to provide you with tailored solutions for your drug discovery and development needs. Whether you have questions, require more information, or are interested in discussing potential collaborations, our team of experts is just a message away.
Feel free to reach out to us.
Get a quote
Go top